نتائج البحث - Teresa Macarulla

تنقيح النتائج
  1. 1
    Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy

    Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy حسب Helena Verdaguer, Josep Tabernero, Teresa Macarulla

    منشور في 2016
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Novel targeted therapies in the treatment of gastric and esophageal cancer

    Novel targeted therapies in the treatment of gastric and esophageal cancer حسب Josep Tabernero, Teresa Macarulla, Francisco Javier Ramos, José Baselga

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment

    Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment حسب Ignace Vergote, Teresa Macarulla, Fred R. Hirsch, Carsten Hagemann, David S. Miller

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study

    First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review s... حسب Julien Taı̈eb, G. Prager, Davide Melisi, C. Benedikt Westphalen, Nathalie D’Esquermes, Anabel Ferreras, Alfredo Carrato, Teresa Macarulla

    منشور في 2020
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer

    IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer حسب Stephen P. Hack, Wendy Verret, Sohail Mulla, Bo Liu, Yulei Wang, Teresa Macarulla, Zhenggang Ren, Anthony B. El-Khoueiry, Andrew X. Zhu

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidence

    Optimizing the management of locally advanced pancreatic cancer with a focus on induction chemotherapy: Expert opinion based on a review of current evidence حسب Thomas Seufferlein, Pascal Hammel, Jean‐Robert Delpéro, Teresa Macarulla, Per Pfeiffer, Gerald W. Prager, Michele Reni, Massimo Falconi, Philip A. Philip, Eric Van Cutsem

    منشور في 2019
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Efficacy and Safety of the MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series

    Efficacy and Safety of the MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series حسب Noboru Yamamoto, Anthony W. Tolcher, Navid Hafez, Iwona Ługowska, Rodryg Ramlau, Teresa Macarulla, Junxian Geng, Jian Li, Michael Teufel, Angela Märten, Patricia LoRusso

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Biliary tract cancers: SEOM clinical guidelines

    Biliary tract cancers: SEOM clinical guidelines حسب Manuel Benavides, A. Antón, Javier Gállego, María Auxiliadora Gómez, Ana-María Jiménez-Gordo, Adelaida La Casta, Berta Laquente, Teresa Macarulla, J. R. Rodríguez-Mowbray, Joan Maurel

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)

    Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the panc... حسب David Goldstein, Daniel D. Von Hoff, Malcolm J. Moore, Edward Greeno, Giampaolo Tortora, Ramesh K. Ramanathan, Teresa Macarulla, Helen Liu, Richard Pilot, Stefano Ferrara, Brian Lu

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: phase III MPACT trial

    Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: phase III MPACT trial حسب Werner Scheithauer, Ramesh K. Ramanathan, Malcolm J. Moore, Teresa Macarulla, David Goldstein, Pascal Hammel, Volker Kunzmann, Helen Liu, D. McGovern, Alfredo Romano, Daniel D. Von Hoff

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    RATIONALE 301 Study: Tislelizumab Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma

    RATIONALE 301 Study: Tislelizumab Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma حسب Shukui Qin, Richard S. Finn, Masatoshi Kudo, Tim Meyer, Arndt Vogel, Michel Ducreux, Teresa Macarulla, Gianluca Tomasello, Frédéric Boisserie, Jeannie Hou, Xin Li, James Song, Andrew X. Zhu

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study

    First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study حسب Zev A. Wainberg, Tanios Bekaii‐Saab, Patrick M. Boland, Farshid Dayyani, Teresa Macarulla, Kabir Mody, Bruce Belanger, Fiona Maxwell, Yan Moore, Arunthathi Thiagalingam, Tiffany Wang, Bin Zhang, Andrew Dean

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study

    Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study حسب Josep Tabernero, Fortunato Ciardiello, Fernando Rivera, Edith Rodríguez-Braun, Francisco Javier Ramos, Erika Martinelli, M. E. Vega-Villegas, Susana Roselló, Stefan Liebscher, O. Kisker, Teresa Macarulla, José Baselga, Andrés Cervantes

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer

    Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer حسب Eric Van Cutsem, Manuel Hidalgo, Jean‐Luc Canon, Teresa Macarulla, I. Bazin, Elena Poddubskaya, Nebojša Manojlović, Dejan Radenković, Chris Verslype, Éric Raymond, Antonio Cubillo, Armin Schueler, Charles Zhao, Pascal Hammel

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    First-In-Human Phase I Study of Lurbinectedin (PM01183) in Patients with Advanced Solid Tumors

    First-In-Human Phase I Study of Lurbinectedin (PM01183) in Patients with Advanced Solid Tumors حسب María Elena Elez, Josep Tabernero, David Geary, Teresa Macarulla, Soonmo Peter Kang, Carmen Kahatt, Arturo Soto-Matos Pita, Carlos Fernández Teruel, Mariano Siguero, Martín Cullell-Young, Sergio Szyldergemajn, Mark J. Ratain

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

    Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treat... حسب Eric Van Cutsem, Josep Tabernero, Radek Lakomý, Hans Prenen, Jana Prausová, Teresa Macarulla, Paul Ruff, Guy A. Van Hazel, Vladimir Moiseyenko, David Ferry, Joe McKendrick, Jonathan Polikoff, Alexia Tellier, R Castan, Carmen J. Allegra

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Molecular Profiling of Patients with Colorectal Cancer and Matched Targeted Therapy in Phase I Clinical Trials

    Molecular Profiling of Patients with Colorectal Cancer and Matched Targeted Therapy in Phase I Clinical Trials حسب Rodrigo Dienstmann, Danila Serpico, Jordi Rodón, Cristina Saura, Teresa Macarulla, Elena Élez, María Alsina, Jaume Capdevila, José Manuel Pérez-García, Gessamí Sánchez-Ollé, Claudia Aura, Ludmila Prudkin, Stefania Landolfi, Javier Hernández‐Losa, Ana Vivancos, Josep Tabernero

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

    Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer حسب Davide Melisi, Rocio García‐Carbonero, Teresa Macarulla, Denis Pezet, G. Deplanque, Martin Fuchs, Jörg Trojan, Helmut Oettle, Mark Kozloff, Ann Cleverly, Claire Smith, Shawn T. Estrem, Ivelina Gueorguieva, Michael Lahn, Al Blunt, Karim A. Benhadji, Josep Tabernero

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Geographic and Ethnic Heterogeneity of Germline <i>BRCA1</i> or <i>BRCA2</i> Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial

    Geographic and Ethnic Heterogeneity of Germline <i>BRCA1</i> or <i>BRCA2</i> Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO T... حسب Talia Golan, Hedy L. Kindler, Joon Oh Park, Michele Reni, Teresa Macarulla, Pascal Hammel, Eric Van Cutsem, Dirk Arnold, Daniel Hochhauser, David McGuinness, Gershon Y. Locker, Teodora Goranova, Philipp Schatz, Yuzhen Liu, Michael J. Hall

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma

    ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma حسب Helena Verdaguer, Tamara Saurí, Daniel Acosta, Magdalena Guardiola, Alexandre Sierra, Jorge Hernando, Paolo Nucíforo, Josep M. Miquel, Cristina Molero, Sandra Peiró, Queralt Serra-Camprubí, Guillermo Villacampa, Susana Aguilar, Ana Vivancos, Josep Tabernero, Rodrigo Dienstmann, Teresa Macarulla

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: